Andere Sprachen CSPC Pharmaceutical Group Ltd.

Aktien

548183

HK1093012172

1093

Verzögert Hong Kong S.E. Andere Börsenplätze 08:13:45 30.05.2024			% 5 Tage	% 1. Jan.
6.81 ^HKD	+0.89%		+5.75%	-6.20%

28.05.	CSPC PHARMACEUTICAL GROUP LTD. : Nomura bekräftigt seine Kaufempfehlung	ZM
28.05.	CSPC Pharmaceutical Group Limited kündigt Änderungen im Vorstand an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

CSPC Pharmaceutical Group Limited Announces Board Changes	28.05.
CSPC Pharmaceutical Group Limited Approves Final Dividend for the Year Ended December 31, 2023	28.05.
CSPC Pharmaceutical Group's Q1 Profit Rises 12%	27.05.
Wall Street et la City ne répondent plus	27.05.
En Direct des Marchés : Alstom, TotalEnergies, Thales, Atos, Renault, Julius Bär, Tesla...	27.05.
Borsa di Italia: Wall Street e la City non rispondono più	27.05.
IN DIRETTA DAI MERCATI: Azimut, Stellantis, Generali, Leonardo, Mediobanca, Poste Italiane, Recordati, BBVA, Microsoft, Tesla, TSMC, UBS...	27.05.
Bolsa de Madrid: Wall Street y la City ya no responden	27.05.
CSPC Pharmaceutical Group Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	27.05.
CSPC Pharma Gets Clearance for China Clinical Trial of Drug for Metabolism-Related Diseases	17.05.
CSPC Pharmaceutical Group Limited Announces Recombinant Fully Human Anti-bKlotho Monoclonal Antibody Drug Obtains Approval from National Medical Products Administration of the People's Republic of China	17.05.
CSPC Pharma's Flu Medication Gets Registration Approval in China	14.05.
Cspc Pharmaceutical Group Limited Announces That the Peramivir Injection (15Ml:0.15G) (The "Product") Developed by the Group Has Obtained Drug Registration Approval Granted by the National Medical Products Administration of the People's Republic of China, and Is Deemed to Have Passed the Consistency Evaluation of Quality and Efficacy for Generic Drugs	14.05.
CSPC Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023	26.04.
CSPC Pharmaceutical Group Limited Announces Highly Selective Mat2A Inhibitor Obtains Clinical Trial Approval in the U.S	26.04.
CSPC Pharmaceutical's EBT Buys 8.5 Million Shares	24.04.
CSPC Pharmaceutical Group Limited and CSPC Holdings Company Limited Enter into Master Sales Agreement	19.04.
China's drugmakers can't sell mRNA shots but haven't quit yet	19.04.
CSPC Pharmaceutical Group Limited commences an Equity Buyback Plan for 1,190,321,973 shares, representing 10% of its issued share capital, under the authorization approved on May 31, 2023.	16.04.
CSPC Pharma Secures Chinese Nod for Weight Managment Drug Trials	26.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen CSPC Pharmaceutical Group Ltd.

Aktien

548183

HK1093012172

1093

Andere Sprachen

Filter